These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
797 related articles for article (PubMed ID: 33802143)
1. Modulation by Ozone Therapy of Oxidative Stress in Chemotherapy-Induced Peripheral Neuropathy: The Background for a Randomized Clinical Trial. Clavo B; Martínez-Sánchez G; Rodríguez-Esparragón F; Rodríguez-Abreu D; Galván S; Aguiar-Bujanda D; Díaz-Garrido JA; Cañas S; Torres-Mata LB; Fabelo H; Téllez T; Santana-Rodríguez N; Fernández-Pérez L; Marrero-Callico G Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33802143 [TBL] [Abstract][Full Text] [Related]
2. Ozone in Chemotherapy-Induced Peripheral Neuropathy-Current State of Art, Possibilities, and Perspectives. Szklener K; Rudzińska A; Juchaniuk P; Kabała Z; Mańdziuk S Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982352 [TBL] [Abstract][Full Text] [Related]
3. Herbal medicines and chemotherapy induced peripheral neuropathy (CIPN): A critical literature review. Schloss J; Colosimo M; Vitetta L Crit Rev Food Sci Nutr; 2017 Apr; 57(6):1107-1118. PubMed ID: 25849070 [TBL] [Abstract][Full Text] [Related]
4. Goshajinkigan for prevention of chemotherapy-induced peripheral neuropathy: a systematic review and meta-analysis. Kuriyama A; Endo K Support Care Cancer; 2018 Apr; 26(4):1051-1059. PubMed ID: 29280005 [TBL] [Abstract][Full Text] [Related]
5. Statistical identification of predictors for peripheral neuropathy associated with administration of bortezomib, taxanes, oxaliplatin or vincristine using ordered logistic regression analysis. Kanbayashi Y; Hosokawa T; Okamoto K; Konishi H; Otsuji E; Yoshikawa T; Takagi T; Taniwaki M Anticancer Drugs; 2010 Oct; 21(9):877-81. PubMed ID: 20679888 [TBL] [Abstract][Full Text] [Related]
6. A randomised, placebo-controlled trial assessing the efficacy of an oral B group vitamin in preventing the development of chemotherapy-induced peripheral neuropathy (CIPN). Schloss JM; Colosimo M; Airey C; Masci P; Linnane AW; Vitetta L Support Care Cancer; 2017 Jan; 25(1):195-204. PubMed ID: 27612466 [TBL] [Abstract][Full Text] [Related]
7. The preventive effect of sensorimotor- and vibration exercises on the onset of Oxaliplatin- or vinca-alkaloid induced peripheral neuropathies - STOP. Streckmann F; Balke M; Lehmann HC; Rustler V; Koliamitra C; Elter T; Hallek M; Leitzmann M; Steinmetz T; Heinen P; Baumann FT; Bloch W BMC Cancer; 2018 Jan; 18(1):62. PubMed ID: 29316888 [TBL] [Abstract][Full Text] [Related]
8. Manganese- and Platinum-Driven Oxidative and Nitrosative Stress in Oxaliplatin-Associated CIPN with Special Reference to Ca Karlsson JOG; Jynge P Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673932 [TBL] [Abstract][Full Text] [Related]
9. Prevention of chemotherapy-induced peripheral neuropathy: A review of recent findings. Ibrahim EY; Ehrlich BE Crit Rev Oncol Hematol; 2020 Jan; 145():102831. PubMed ID: 31783290 [TBL] [Abstract][Full Text] [Related]
10. Oral glutamine for the prevention of chemotherapy-induced peripheral neuropathy. Amara S Ann Pharmacother; 2008 Oct; 42(10):1481-5. PubMed ID: 18698011 [TBL] [Abstract][Full Text] [Related]
11. Ganglioside-monosialic acid (GM1) for prevention of chemotherapy-induced peripheral neuropathy: a meta-analysis with trial sequential analysis. Wu S; Bai X; Guo C; Huang Z; Ouyang H; Huang J; Zeng W BMC Cancer; 2021 Nov; 21(1):1173. PubMed ID: 34727879 [TBL] [Abstract][Full Text] [Related]